The LLS Blog Read about survivors, research, fundraising, and advocacy. The LLS Blog Read about survivors, research, fundraising, and advocacy. Topic - AllNoneAthletic EventsBig ClimbCOVID-19Dare to DreamDisease InformationEducation/SupportFDA ApprovalsFinancial AssistanceHomepageLight The NightLLS News/StatementsNavigating Your CarePolicy/AdvocacyResearchStudent Visionaries of the YearVisionaries of the Year Sort by - LatestOlder FDA Approves New Option for Difficult to Treat, Rare Form of Childhood Leukemia May 26, 2022 More Than 5 Million New Yorkers Are Getting "In-Network" Access to Top Cancer Centers April 13, 2022 CAR T-Cell Therapy Approved for Initial Treatment of Relapsed Large B-Cell Lymphoma April 5, 2022 New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma March 1, 2022 Walgreens, The Leukemia & Lymphoma Society and Susan G. Komen Collaborating to Support Research in Tough-to-Treat Cancers and Increase Access to Care February 23, 2022 Highlights from ASH 2021 December 21, 2021 FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia November 11, 2021 LLS and Burlington Celebrate 20 years of Fighting Blood Cancer Together! October 18, 2021 LLS makes progress for blood cancer patients through virtual advocacy July 15, 2021 Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
